Trending Articles

  1. Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to...
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    ADC funding, spatial biology investment and haematology M&A signal biopharma pipeline momentum From a $86.6m Series B for first-in-class ADCs to a $1.25bn haematology acquisition, this week's deals reflect sustained biopharma investment in next-generation therapeutic...
  3. Strengthening US pharmaceutical supply: SCHOTT Pharma inaugurates expanded vial production in Lebanon, PA SCHOTT Pharma has inaugurated new production lines for both standard and sterile ready-to-use (RTU) glass vials designed to store a wide range of drugs — from biologics and...
  4. T-CURX acquires Pantherna Therapeutics to fast-track non-viral in vivo CAR-T pipeline Combining transposon-based CAR-T with Pantherna's LNP and mRNA platforms, T-CURX aims to accelerate clinical trials by a year and become Europe's first biotech with both...
  5. CordenPharma acquires AmbioPharm to build three-continent peptide API network The deal adds US and Shanghai manufacturing sites to CordenPharma's existing platform, giving pharma customers greater flexibility across SPPS, LPPS and hybrid peptide...

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

You may also like

Finance The ARK Venture Fund has previously invested in tech platforms such as OpenAI and Anthropic and is now backing the life sciences company to solve cell therapy's scaling problem

ARK Invest backs Cellares to mass manufacture cell therapies with $20m investment

Read more
Manufacturing AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and...

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

Read more
Finance GSK has agreed to acquire clinical-stage oncology company Nuvalent for $10.6bn, securing two late-stage next-generation kinase inhibitors — zidesamtinib and neladalkib —...

GSK acquires Nuvalent for $10.6bn to accelerate NSCLC pipeline with FDA-reviewed ROS1 and ALK inhibitors

Read more
Finance Heligan Group's latest report records just 53 deals, down from 72 in Q1 2025, with pharma and life sciences remaining most active despite tighter financing conditions and...

UK healthcare M&A drops 26% in Q1 2026 amid geopolitical tension and financing pressures

Read more
Finance From a $86.6m Series B for first-in-class ADCs to a $1.25bn haematology acquisition, this week's deals reflect sustained biopharma investment in next-generation therapeutic...

ADC funding, spatial biology investment and haematology M&A signal biopharma pipeline momentum

Read more
Finance SCHOTT Pharma has inaugurated new production lines for both standard and sterile ready-to-use (RTU) glass vials designed to store a wide range of drugs — from biologics and...

Strengthening US pharmaceutical supply: SCHOTT Pharma inaugurates expanded vial production in Lebanon, PA

Read more
Manufacturing After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to...

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

Read more
Finance Combining transposon-based CAR-T with Pantherna's LNP and mRNA platforms, T-CURX aims to accelerate clinical trials by a year and become Europe's first biotech with both...

T-CURX acquires Pantherna Therapeutics to fast-track non-viral in vivo CAR-T pipeline

Read more
Manufacturing The deal adds US and Shanghai manufacturing sites to CordenPharma's existing platform, giving pharma customers greater flexibility across SPPS, LPPS and hybrid peptide...

CordenPharma acquires AmbioPharm to build three-continent peptide API network

Read more
Manufacturing Revenue rises to £1.1 billion as profit increases 16% and workforce expands to more than 7,900 amid continued global investment programme

Almac group delivers record year of growth

Read more
Finance The pharma giant has reportedly agreed to acquire Curevo, LimmaTech Biologics and Vaccine Co in a strategic push beyond its blockbuster obesity franchise

Eli Lilly to expand into infectious disease with $4bn triple vaccine acquisition

Read more
Manufacturing New platform leverages the established Curator platform methodology to industrialise Lentivirus processes from concept to clinic

Andelyn Biosciences launches LVV Curator platform, bringing proven viral vector platform pedigree to Lentiviral Vector manufacturing for cell therapies

Read more
Manufacturing Co-CEOs for the transition period, António Almeida and Dr. Marco Gil, bring combined 40 years of experience with Hovione to their new role

Hovione announces leadership transition and interim Co-CEO structure

Read more
Manufacturing The purchase will hand the Group a biologics drug substance manufacturing facility and a warehousing centre in Maryland, which Bora plans to use in cooperation with Tanvex...

Bora Group to acquire MacroGenics’ manufacturing operations and CDMO business

Read more
Finance The investment will advance a handheld device delivering more precise and reproducible tumour size measurements in preclinical oncology research, addressing variability in...

Cambridge biotech Verinnogen secures £500k CPI investment to advance cancer drug development

Read more
Manufacturing Munich, Germany – May 7th, 2026 – Adragos Pharma, a global contract development and manufacturing organisation (CDMO), today announced the appointment of Konstantinos...

Adragos Pharma appoints Kostas Rengis as Chief Executive Officer

Read more